Virinchi is currently trading at Rs. 114.50, up by 11.65 points or 11.33% from its previous closing of Rs. 102.85 on the BSE.
The scrip opened at Rs. 104.50 and has touched a high and low of Rs. 117.00 and Rs. 104.50 respectively. So far 95505 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 153.50 on 09-Jan-2018 and a 52 week low of Rs. 66.70 on 23-Aug-2017.
Last one week high and low of the scrip stood at Rs. 117.00 and Rs. 101.50 respectively. The current market cap of the company is Rs. 326.33 crore.
The promoters holding in the company stood at 47.58%, while Institutions and Non-Institutions held 0.43% and 52.00% respectively.
Virinchi has commenced project work for Phase 2 of the healthcare expansion at Banjara Hills facility to service economy patients to maximize from the new initiatives of GOI viz., Ayushman Bharat etc. and also start full-fledged Oncology department. Phase 2 of healthcare expansion would consist of 150 economy and 100 Oncology beds, costing around Rs 70 to 80 crore.
The capital works on 50 economy beds has been underway since last two quarters with internal accruals. The Radiation Oncology involving bunkers to house Linear accelerators will require 12-14 months for completion. With completion of Phase 2, all of the planned 800 beds of the Banjara Hills facility will be operational, providing patient services in over 40 clinical departments.
Virinchi is an IT Products & Services company listed on Bombay Stock Exchange (BSE), India, focusing on customers in North America, Europe, & Middle East.
Company Name | CMP |
---|---|
TCS | 3880.35 |
Infosys | 1420.75 |
HCL Tech. | 1333.55 |
Wipro | 458.10 |
Tech Mahindra | 1276.00 |
View more.. |